NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

53 hedge funds and large institutions have $3.91M invested in Navidea Biopharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
26
Jane Street
New York
$11K +$11K +2,335 New
Invesco
27
Invesco
Georgia
$9K -$2.57K -534 -22%
Citigroup
28
Citigroup
New York
$9K
Bank of America
29
Bank of America
North Carolina
$8K
LFG
30
LifePlan Financial Group
Ohio
$7K
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$7K
USAA
32
United Services Automobile Association
Texas
$6K
JCM
33
Jacobi Capital Management
Pennsylvania
$5K -$35 -7 -0.7%
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$5K
LA
35
Lynch & Associates
Indiana
$4K
RJA
36
Raymond James & Associates
Florida
$4K
MCG
37
McCollum Christoferson Group
New York
$4K
SIS
38
Sound Income Strategies
Florida
$3K
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$3K
HC
40
Hamilton Capital
Ohio
$3K
BO
41
BRR OpCo
Ohio
$3K +$3K +638 New
MWPCG
42
Measured Wealth Private Client Group
New Hampshire
$2K
CIBC World Market
43
CIBC World Market
Ontario, Canada
$2K
B
44
Bailard
California
$2K
CPIG
45
Chicago Partners Investment Group
Illinois
$1K
ASN
46
Advisory Services Network
Georgia
$1K
MFW
47
Mosaic Family Wealth
Missouri
$1K
AWM
48
Aevitas Wealth Management
Massachusetts
$1K
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$1K
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
-$81K -17,660 Closed